Thus, we speculated HBV may inhibit the ubiquitin-proteasome degradation of DHX9 by phosphorylating UHRF2 at serine 643, and upregulating DHX9 protein levels to promotes HBV replication and HCC development. This evidence concerns the gene UHRF2 and hepatocellular carcinoma.